Be in the know. 20 key reads for Tuesday…

  1. Pfizer lifts sales forecast for COVID-19 vaccine to $26 billion (Reuters)
  2. Pfizer (PFE) Tops Q1 EPS by 15c, Raises FY Guidance (StreetInsider)
  3. Pfizer plans to file for full FDA approval of Covid vaccine at the end of this month (CNBC)
  4. Clorox is still selling many more cleaning products than it was pre-pandemic (MarketWatch)
  5. Consumer Lenders Face a New Challenge: Each Other (Wall Street Journal)
  6. Starboard Value Finally Makes Its Move on Box (Barron’s)
  7. How Inflation Could Shape the Next Phase of the Stock Market (Barron’s)
  8. U.S. Stock Market Futures Mixed, With Airlines Lifted by Travel Reopening Plans in Europe (Barron’s)
  9. Apple and Epic Games Trial Has Started. What to Know. (Barron’s)
  10. Bank Stocks Continue to Gain. Why Wall Street Says the Rally Still Has Steam. (Barron’s)
  11. Why Ether is Soaring to New Highs (Barron’s)
  12. The world risks ‘running out of copper’ — and here’s how high prices may rise as the economy reopens, BofA warns (MarketWatch)
  13. The Fed Doesn’t Want to Talk Tapering Yet. Wait for Summer, Wall Street Says. (Barron’s)
  14. ‘Buy in May and go away’: Why US stocks can trade higher into the summer months, according to JPMorgan’s quant guru (Business Insider)
  15. Mohamed El-Erian says inflation is here to stay and won’t be ‘transitory’ like the Fed claims (Business Insider)
  16. Why supply-chain bottlenecks, price pressures may ease by year end (MarketWatch)
  17. OPEC Keeps Crude Production Steady Before Planned Increases (Bloomberg)
  18. UPDATE 2-ConocoPhillips profit tops as travel demand boosts oil prices (Reuters)
  19. New York, New Jersey Lift Covid-19 Capacity Limits on Businesses (Wall Street Journal)
  20. Record Share of Companies Are Beating Earnings Estimates (Wall Street Journal)